RAZA SAIYED ATIQ sold $131K of AIP (indirect holdings)
RAZA SAIYED ATIQ sold 3,600 indirectly-held shares of Arteris, Inc. (AIP) at $36.45 ($0.13M total) on 2026-06-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed open-market sale by a director can affect short-term sentiment, but the pre-arranged 10b5-1 plan reduces the likelihood of a timing-based signal.
Market read
AIP receives a new insider-selling datapoint, but it is pre-planned under Rule 10b5-1, implying limited incremental fundamental information.
What to watch
The filing does not indicate whether other insiders/funds are buying or whether fundamentals changed; without additional news, interpret cautiously.
Background
The article is an SEC Form 4 insider transaction disclosure for Arteris, Inc. (AIP).
Ticker impact
Arteris director RAZA SAIYED ATIQ sold 3,600 shares in an open-market transaction under a pre-arranged 10b5-1 plan.
Low-to-mild negative drift possible around disclosure, with limited follow-through expected absent other catalysts.
The filing is a disclosed sale (not a buy) but explicitly tied to a pre-arranged 10b5-1 plan, reducing interpretation of timing/intent.
Market effects
Minimal; this is company-specific insider activity with no stated sector-wide catalyst.
None indicated.
None indicated.
Counterpoint
Because the sale is under a 10b5-1 plan, it may be routine liquidity rather than bearish information; price reaction could be overdone.
Key entities
- issuerArteris, Inc.
US-listed company whose director disclosed an open-market sale under a 10b5-1 plan.
- insiderRAZA SAIYED ATIQ
Director who sold 3,600 shares on 2026-06-01; indirect ownership; holdings after: 140,000 shares.
